Press releases

ISTANBUL - April 7, 2014 - Medtronic, Inc. today announced that one of its subsidiaries has acquired a majority of the shares of Biostar, which will assume the distribution of Medtronic products...

LONDON -- April 5, 2014 --Patients with peripheral artery disease in the upper leg experienced significantly better outcomes at 12 months after treatment with the IN.PACT Admiral drug-coated...

MINNEAPOLIS - March 31, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the final follow-up results from the CoreValve® CE Pivotal Study, which demonstrated excellent long-term durability at...

MINNEAPOLIS - March 6, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the European Patent Office (EPO) has invalidated, in its entirety, the Edwards Lifesciences EP2055266 Spenser patent...

MINNEAPOLIS and WASHINGTON, D.C. - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), announced today further analysis of six-month follow-up data from the first 1,000 patients enrolled in the Global...

MINNEAPOLIS and WASHINGTON - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the one-year results of the Melody® Transcatheter Pulmonary Valve (TPV) U.S. Post-Approval Study, which...

MINNEAPOLIS and WASHINGTON - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the CoreValve® System showed results superior to surgical aortic valve replacement (SAVR) at one...

MINNEAPOLIS and WASHINGTON, DC - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the full results of the SYMPLICITY HTN-3 clinical trial, which were presented today in late-breaking...

DENVER, Colo. and DUBLIN, Ireland – March 28, 2014 – In a move aimed at giving nursing professionals the tools they need to address rapidly changing practices and cost structures, the AORN...

Minneapolis - March 27, 2014 -Medtronic, Inc. (NYSE:MDT) today announced the first patients were enrolled in the Improve SCA Clinical Study, a first-of-its-kind study that will identify patients...

DUBLIN--(BUSINESS WIRE)--Mar. 25, 2014-- An innovative Covidien (NYSE: COV) technology is effective at treating Barrett’s esophagus (a precancerous condition of the esophagus), according to a...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE:COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE: COV) announced the results from today’s Annual General Meeting. Seven proposals were on the meeting agenda: Election of...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 14, 2014-- Covidien plc (NYSE: COV) will report second-quarter fiscal 2014 results on April 25. The company will host a conference call for investors at 8:30...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 13, 2014-- Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite...

MINNEAPOLIS - March 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today applications are open to runners around the world who benefit from medical technology to represent their country on the...

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 6, 2014-- Covidien plc (NYSE: COV) will present at the Barclays Global Healthcare Conference 2014 in Miami on March 13. Charles J. Dockendorff, executive...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 3, 2014-- Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care...

HARTFORD, Conn. and MINNEAPOLIS, March 3, 2014 - Beginning this month, Aetna (NYSE: AET) and Medtronic, Inc. (NYSE: MDT) will work with doctors in a new program to reach up to 300 fully insured...

MINNEAPOLIS - Mar 6, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Barclays Global Healthcare Conference on...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 27, 2014-- Covidien plc (NYSE: COV) today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

MINNEAPOLIS - Feb 27, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Cowen and Company 34th Annual Healthcare...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...